West Pharmaceutical Services Inc (WST)-医療機器分野:企業M&A・提携分析

◆英語タイトル:West Pharmaceutical Services Inc (WST) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011939
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and systems for packaging and delivery of injectable drugs and delivery system components for use healthcare, pharmaceuticals and consumer product industries. Its product and services include stoppers and seals for vials, components for intravenous and blood collection systems, prefillable syringe components and systems, advanced injection systems, safety and administration systems, contract design and manufacturing services. The company caters its products to pharmaceutical, biotechnology, generic drug and medical devices companies. It has manufacturing facilities in North America, South America, Europe and Asia-Pacific with affiliated companies in Mexico and Japan. West Pharmaceutical is headquartered in Exton, Pennsylvania, the US.

West Pharmaceutical Services Inc (WST) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
West Pharmaceutical Services Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
West Pharmaceutical Services Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
West Pharmaceutical Services Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
West Pharmaceutical Services Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
West Pharmaceutical Services Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
West Pharmaceutical Services Inc, Medical Equipment, Deal Details 11
Partnerships 11
Gerresheimer Enters into Licensing Agreement with West Pharma 11
West Pharma Enters Into Co-Development Agreement With Janssen Biotech 12
West Pharma Enters Into Agreement With CareFusion 13
Debt Offering 14
West Pharma Completes Private Placement Of 3.67% Series A Senior Notes Due 2022 For US$42 Million 14
West Pharma Completes Private Placement Of 3.82% Series B Senior Notes Due 2024 For US$53 Million 15
West Pharma Completes Private Placement Of Series C Senior Notes Due 2027 For US$73 Million 16
Acquisition 17
West Pharma Invests in NanoPass Technologies 17
West Pharmaceutical Services Inc – Key Competitors 18
West Pharmaceutical Services Inc – Key Employees 19
West Pharmaceutical Services Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Strategy And Business Planning 23
Nov 29, 2016: West Announces Expanded Contract Manufacturing Capabilities in Ireland 23
Jan 20, 2016: West and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems 24
Financial Announcements 25
Oct 26, 2017: West Announces Third-Quarter 2017 Results 25
Jul 27, 2017: West Announces Second-Quarter 2017 Results 27
Apr 27, 2017: West Announces First-Quarter 2017 Results 29
Feb 16, 2017: West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend 31
Oct 27, 2016: West Announces Third Quarter 2016 Results 34
Jul 28, 2016: West Announces Second Quarter 2016 Results 36
Apr 28, 2016: West Announces First Quarter 2016 Results 38
Feb 18, 2016: West Announces Fourth Quarter and Full-Year 2015 Results 40
Corporate Communications 43
Jun 01, 2017: West Elects New Director to the Board 43
Sep 26, 2016: West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain 44
Sep 12, 2016: West Elects New Director and Announces Increase to Quarterly Dividend 45
Mar 01, 2016: West Appoints Eric Resnick to Chief Technology Officer 46
Product News 47
May 30, 2017: West to Present on Biologics Trends at InnoPack Pharma Confex 47
May 03, 2017: West Highlights Company Scientific and Regulatory Expertise at Notable Industry Meetings 48
Oct 17, 2016: West to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices 50
Jun 07, 2016: West Introduces 1-3mL NovaPure Plunger for Higher Volume Injections 52
Other Significant Developments 53
Feb 12, 2016: West’s Daikyo Crystal Zenith Cyclic Olefin Polymer Selected by Amgen 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
West Pharmaceutical Services Inc, Medical Equipment, Key Facts, 2016 2
West Pharmaceutical Services Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
West Pharmaceutical Services Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
West Pharmaceutical Services Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
West Pharmaceutical Services Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
West Pharmaceutical Services Inc, Deals By Market, 2011 to YTD 2017 9
West Pharmaceutical Services Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Gerresheimer Enters into Licensing Agreement with West Pharma 11
West Pharma Enters Into Co-Development Agreement With Janssen Biotech 12
West Pharma Enters Into Agreement With CareFusion 13
West Pharma Completes Private Placement Of 3.67% Series A Senior Notes Due 2022 For US$42 Million 14
West Pharma Completes Private Placement Of 3.82% Series B Senior Notes Due 2024 For US$53 Million 15
West Pharma Completes Private Placement Of Series C Senior Notes Due 2027 For US$73 Million 16
West Pharma Invests in NanoPass Technologies 17
West Pharmaceutical Services Inc, Key Competitors 18
West Pharmaceutical Services Inc, Key Employees 19
West Pharmaceutical Services Inc, Other Locations 21
West Pharmaceutical Services Inc, Subsidiaries 21

★海外企業調査レポート[West Pharmaceutical Services Inc (WST)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ambry Genetics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Ambry Genetics Corp (Ambry Genetics), a subsidiary of Konica Minolta Inc, is a provider of clinical genetic testing services. The company provides genetic diagnosis for various conditions including hereditary cancer, epilepsy, hereditary cardiovascular disease and neurodevelopmental disorder …
  • China Vanke Co., Ltd.:企業のM&A・事業提携・投資動向
    China Vanke Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Vanke Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • North Carolina Biotechnology Center-製薬・医療分野:企業M&A・提携分析
    Summary North Carolina Biotechnology Center (NCBiotech) is a life-science service provider that offers economic development services. The organization provides hamner conference center, office space for rent, and biotech business library services. It offers meeting space, catering, rooms and service …
  • Fagron NV (FAGR):企業の財務・戦略的SWOT分析
    Summary Fagron NV (Fagron), is a pharmaceutical company that provides compounding solutions. The company offers products such as raw materials, flammable products, extracts and tinctures; anesthetic, syrups, ointment bases, medispend, triturations, suspension media, phyto pharmaflore, capsicards sys …
  • Taiheiyo Cement Corporation:企業の戦略・SWOT・財務分析
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • FibroGen Inc (FGEN)-製薬・医療分野:企業M&A・提携分析
    Summary FibroGen Inc (FibroGen) is a biotechnology company that discovers, develops and commercializes new therapeutics. The company’s pipeline product portfolio includes FG-4592, an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in chronic kidney d …
  • Harvey Gulf International Marine LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Harvey Gulf International Marine LLC (Harvey Gulf), formerly Harvey Canal Towing Company is a marine transportation company that provides offshore supply and multi-purpose support vessels for deep-water operations. The company offers offshore supply vessel services, offshore mooring line sup …
  • PeptiDream Inc (4587):製薬・医療:M&Aディール及び事業提携情報
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Tufts University-製薬・医療分野:企業M&A・提携分析
    Summary Tufts University (Tufts) is an educational and research university that offers undergraduate and postgraduate courses in various fields. The university offer courses in anthropology, applied mathematics, architectural engineering, physics, archaeology, Asian American studies, biochemistry, b …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Platinum Group Metals Ltd (PTM):企業の財務・戦略的SWOT分析
    Platinum Group Metals Ltd (PTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Hrvatski Telekom dd (HT-R-A):企業の財務・戦略的SWOT分析
    Hrvatski Telekom dd (HT-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Nippon Synthetic Chemical Industry Co., Ltd.:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Central National-Gottesman Inc.:企業の戦略・SWOT・財務情報
    Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report Summary Central National-Gottesman Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Vertex Pharmaceuticals Inc (VRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that carries out the discovery, development and commercialization of transformative drugs for the treatment of serious and life-threatening diseases. The company product portfolio includes Orkambi (ivacaftor/lumacaftor) and Kalyd …
  • Wistron Corporation:企業の戦略・SWOT・財務分析
    Wistron Corporation - Strategy, SWOT and Corporate Finance Report Summary Wistron Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Orbus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbus Therapeutics Inc (Orbus Therapeutics) is a clinical-stage biopharmaceutical company that develops and commercializes drugs for the treatment of anaplastic astrocytoma, a rare kind of cancer afflicting the central nervous system. Eflornithine, a cytostatic agent, indicated for the treat …
  • Rexahn Pharmaceuticals Inc (RNN):企業の財務・戦略的SWOT分析
    Summary Rexahn Pharmaceuticals Inc (Rexahn Pharmaceuticals), formerly Corporate Road Show.com Inc is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer. The company develops anti-cancer drug candidates including Archexin that is intended for the tre …
  • Magellan Midstream Partners, L.P.:企業の戦略・SWOT・財務情報
    Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Polpharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆